• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在表达组织蛋白酶-K 的细胞中诱导 Lrp5 HBM 突变会改变骨代谢。

Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.

机构信息

Department of Anatomy & Cell Biology, Indiana University School of Medicine, Indianapolis, IN, USA; Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA; School of Physical Science & Engineering, Anderson University, Anderson, IN, USA.

Department of Biomedical & Applied Sciences, Indiana University School of Dentistry, Indianapolis, IN, USA.

出版信息

Bone. 2019 Mar;120:166-175. doi: 10.1016/j.bone.2018.10.007. Epub 2018 Oct 25.

DOI:10.1016/j.bone.2018.10.007
PMID:30409757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6360125/
Abstract

High-bone-mass (HBM)-causing missense mutations in the low density lipoprotein receptor-related protein-5 (Lrp5) are associated with increased osteoanabolic action and protection from disuse- and ovariectomy-induced osteopenia. These mutations (e.g., A214V and G171V) confer resistance to endogenous secreted Lrp5/6 inhibitors, such as sclerostin (SOST) and Dickkopf homolog-1 (DKK1). Cells in the osteoblast lineage are responsive to canonical Wnt stimulation, but recent work has indicated that osteoclasts exhibit both indirect and direct responsiveness to canonical Wnt. Whether Lrp5-HBM receptors, expressed in osteoclasts, might alter osteoclast differentiation, activity, and consequent net bone balance in the skeleton, is not known. To address this, we bred mice harboring heterozygous Lrp5 HBM-causing conditional knock-in alleles to Ctsk-Cre transgenic mice and studied the phenotype using DXA, μCT, histomorphometry, serum assays, and primary cell culture. Mice with HBM alleles induced in Ctsk-expressing cells (TG) exhibited higher bone mass and architectural properties compared to non-transgenic (NTG) counterparts. In vivo and in vitro measurements of osteoclast activity, population density, and differentiation yielded significant reductions in osteoclast-related parameters in female but not male TG mice. Droplet digital PCR performed on osteocyte enriched cortical bone tubes from TG and NTG mice revealed that ~8-17% of the osteocyte population (depending on sex) underwent recombination of the conditional Lrp5 allele in the presence of Ctsk-Cre. Further, bone formation parameters in the midshaft femur cortex show a small but significant increase in anabolic action on the endocortical but not periosteal surface. These findings suggest that Wnt/Lrp5 signaling in osteoclasts affects osteoclastogenesis and activity in female mice, but also that some of the changes in bone mass in TG mice might be due to Cre expression in the osteocyte population.

摘要

高骨量(HBM)导致低密度脂蛋白受体相关蛋白 5(Lrp5)的错义突变与增加的成骨作用和防止废用性和卵巢切除引起的骨质疏松有关。这些突变(例如 A214V 和 G171V)使内源性分泌的 Lrp5/6 抑制剂,如硬化蛋白(SOST)和 Dickkopf 同源物-1(DKK1)抵抗。成骨细胞谱系中的细胞对经典 Wnt 刺激有反应,但最近的工作表明破骨细胞对经典 Wnt 表现出间接和直接反应。在破骨细胞中表达的 Lrp5-HBM 受体是否会改变破骨细胞分化、活性以及随后对骨骼中净骨平衡的影响尚不清楚。为了解决这个问题,我们将携带杂合 Lrp5 HBM 致条件敲入等位基因的小鼠与 Ctsk-Cre 转基因小鼠杂交,并使用 DXA、μCT、组织形态计量学、血清测定和原代细胞培养研究表型。在 Ctsk 表达细胞中诱导 HBM 等位基因的小鼠(TG)与非转基因(NTG)对照相比,表现出更高的骨量和骨结构特性。体内和体外的破骨细胞活性、种群密度和分化测量表明,在雌性 TG 小鼠中,破骨细胞相关参数显著降低,但在雄性 TG 小鼠中没有。在 TG 和 NTG 小鼠的骨细胞丰富的皮质骨管上进行的液滴数字 PCR 显示,在存在 Ctsk-Cre 的情况下,约 8-17%的骨细胞群体(取决于性别)经历了条件 Lrp5 等位基因的重组。此外,中股骨皮质的骨形成参数显示,在内皮质而非骨膜表面的骨形成作用有一个小但显著的增加。这些发现表明,破骨细胞中的 Wnt/Lrp5 信号传导影响雌性小鼠的破骨细胞发生和活性,但也表明 TG 小鼠骨量变化的部分原因可能是 Cre 在骨细胞群体中的表达。

相似文献

1
Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.在表达组织蛋白酶-K 的细胞中诱导 Lrp5 HBM 突变会改变骨代谢。
Bone. 2019 Mar;120:166-175. doi: 10.1016/j.bone.2018.10.007. Epub 2018 Oct 25.
2
High Bone Mass-Causing Mutant LRP5 Receptors Are Resistant to Endogenous Inhibitors In Vivo.导致高骨量的突变型LRP5受体在体内对内源性抑制剂具有抗性。
J Bone Miner Res. 2015 Oct;30(10):1822-30. doi: 10.1002/jbmr.2514.
3
The high-bone-mass phenotype of novel transgenic mice with LRP5 A241T mutation.新型 LRP5 A241T 突变转基因小鼠的高骨量表型。
Bone. 2024 Oct;187:117172. doi: 10.1016/j.bone.2024.117172. Epub 2024 Jun 21.
4
New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.常染色体显性遗传性骨量增多症的新解释:载脂蛋白 E 受体相关蛋白 6 基因突变。
Bone. 2019 Oct;127:228-243. doi: 10.1016/j.bone.2019.05.003. Epub 2019 May 11.
5
The Anti-Osteoanabolic Function of Sclerostin Is Blunted in Mice Carrying a High Bone Mass Mutation of Lrp5.在携带Lrp5高骨量突变的小鼠中,硬化蛋白的抗骨合成代谢功能减弱。
J Bone Miner Res. 2015 Jul;30(7):1175-83. doi: 10.1002/jbmr.2461. Epub 2015 Jun 8.
6
Mechanotransduction in bone tissue: The A214V and G171V mutations in Lrp5 enhance load-induced osteogenesis in a surface-selective manner.骨组织中的力学转导:LRP5 中的 A214V 和 G171V 突变以表面选择性方式增强载荷诱导的成骨作用。
Bone. 2012 Sep;51(3):459-65. doi: 10.1016/j.bone.2012.05.023. Epub 2012 Jun 28.
7
Missense Mutations in LRP5 Associated with High Bone Mass Protect the Mouse Skeleton from Disuse- and Ovariectomy-Induced Osteopenia.与高骨量相关的LRP5错义突变可保护小鼠骨骼免受废用性和卵巢切除诱导的骨质减少。
PLoS One. 2015 Nov 10;10(11):e0140775. doi: 10.1371/journal.pone.0140775. eCollection 2015.
8
Analysis of multiple bone responses to graded strains above functional levels, and to disuse, in mice in vivo show that the human Lrp5 G171V High Bone Mass mutation increases the osteogenic response to loading but that lack of Lrp5 activity reduces it.对活体小鼠体内功能水平以上的分级应变和废用的多种骨骼反应的分析表明,人类 Lrp5 G171V 高骨量突变增加了对加载的成骨反应,但缺乏 Lrp5 活性会降低这种反应。
Bone. 2011 Aug;49(2):184-93. doi: 10.1016/j.bone.2011.03.683. Epub 2011 Mar 16.
9
The LRP5 high-bone-mass mutation causes alveolar bone accrual with minor craniofacial alteration.LRP5 高骨量突变导致肺泡骨积累和轻微的颅面改变。
J Periodontal Res. 2023 Aug;58(4):723-732. doi: 10.1111/jre.13130. Epub 2023 May 2.
10
High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypes.Wnt 信号通路中的高骨量产生突变导致不同的骨骼表型。
Bone. 2011 Nov;49(5):1010-9. doi: 10.1016/j.bone.2011.07.034. Epub 2011 Aug 9.

引用本文的文献

1
The PDE4 Inhibitors Roflumilast and Rolipram Rescue ADO2 Osteoclast Resorption Dysfunction.PDE4 抑制剂罗氟司特和罗利普兰可挽救 ADO2 破骨细胞吸收功能障碍。
Calcif Tissue Int. 2024 Apr;114(4):430-443. doi: 10.1007/s00223-024-01191-7. Epub 2024 Mar 14.
2
Discovery of CTSK+ Periosteal Stem Cells Mediating Bone Repair in Orbital Reconstruction.发现 CTSK+骨膜干细胞在眼眶重建中介导骨修复。
Invest Ophthalmol Vis Sci. 2023 Aug 1;64(11):30. doi: 10.1167/iovs.64.11.30.
3
Sostdc1 Suppression in the Absence of Sclerostin Potentiates Anabolic Action of Cortical Bone in Mice.骨硬化蛋白缺失时 Sostdc1 的抑制增强了小鼠皮质骨的合成代谢作用。
J Bone Miner Res. 2023 May;38(5):765-774. doi: 10.1002/jbmr.4798. Epub 2023 Mar 22.
4
Perspective: The current state of Cre driver mouse lines in skeletal research: Challenges and opportunities.观点:骨骼研究中 Cre 驱动鼠系的现状:挑战与机遇。
Bone. 2023 May;170:116719. doi: 10.1016/j.bone.2023.116719. Epub 2023 Mar 1.
5
Strategies of Macrophages to Maintain Bone Homeostasis and Promote Bone Repair: A Narrative Review.巨噬细胞维持骨稳态和促进骨修复的策略:一篇综述
J Funct Biomater. 2022 Dec 29;14(1):18. doi: 10.3390/jfb14010018.
6
Zebrafish mutants reveal unexpected role of Lrp5 in osteoclast regulation.斑马鱼突变体揭示了 Lrp5 在破骨细胞调节中的意外作用。
Front Endocrinol (Lausanne). 2022 Sep 2;13:985304. doi: 10.3389/fendo.2022.985304. eCollection 2022.
7
Wnt Pathway Extracellular Components and Their Essential Roles in Bone Homeostasis.Wnt 通路细胞外成分及其在骨稳态中的重要作用。
Genes (Basel). 2022 Jan 13;13(1):138. doi: 10.3390/genes13010138.
8
Sex-specific differences in direct osteoclastic indirect osteoblastic effects underlay the low bone mass of Pannexin1 deletion in TRAP-expressing cells in mice.小鼠中表达抗酒石酸酸性磷酸酶的细胞中泛连接蛋白1缺失导致的低骨量,其基础是破骨细胞直接和成骨细胞间接作用的性别特异性差异。
Bone Rep. 2022 Jan 4;16:101164. doi: 10.1016/j.bonr.2021.101164. eCollection 2022 Jun.
9
Mechanical Loading-Driven Tumor Suppression Is Mediated by Lrp5-Dependent and Independent Mechanisms.机械负荷驱动的肿瘤抑制由依赖和不依赖Lrp5的机制介导。
Cancers (Basel). 2021 Jan 13;13(2):267. doi: 10.3390/cancers13020267.

本文引用的文献

1
Adult-Onset Deletion of β-Catenin in (10kb)Dmp1-Expressing Cells Prevents Intermittent PTH-Induced Bone Gain.成年期在表达(10kb)Dmp1的细胞中β-连环蛋白的缺失可阻止间歇性甲状旁腺激素诱导的骨量增加。
Endocrinology. 2016 Aug;157(8):3047-57. doi: 10.1210/en.2015-1587. Epub 2016 Jun 2.
2
Runx2 Controls Bone Resorption through the Down-Regulation of the Wnt Pathway in Osteoblasts.Runx2通过下调成骨细胞中的Wnt信号通路来控制骨吸收。
Am J Pathol. 2016 Jun;186(6):1598-609. doi: 10.1016/j.ajpath.2016.01.016. Epub 2016 Apr 12.
3
Missense Mutations in LRP5 Associated with High Bone Mass Protect the Mouse Skeleton from Disuse- and Ovariectomy-Induced Osteopenia.与高骨量相关的LRP5错义突变可保护小鼠骨骼免受废用性和卵巢切除诱导的骨质减少。
PLoS One. 2015 Nov 10;10(11):e0140775. doi: 10.1371/journal.pone.0140775. eCollection 2015.
4
Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways.Wnt信号通路通过激活经典和非经典的cAMP/PKA信号通路来抑制破骨细胞分化。
J Bone Miner Res. 2016 Jan;31(1):65-75. doi: 10.1002/jbmr.2599. Epub 2015 Aug 19.
5
The WNT system: background and its role in bone.WNT 系统:背景及其在骨骼中的作用。
J Intern Med. 2015 Jun;277(6):630-49. doi: 10.1111/joim.12368.
6
Wnt5a/Ror2 mediates temporomandibular joint subchondral bone remodeling.Wnt5a/Ror2介导颞下颌关节软骨下骨重塑。
J Dent Res. 2015 Jun;94(6):803-12. doi: 10.1177/0022034515576051. Epub 2015 Mar 6.
7
Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA.淋巴管及其他血管畸形/过度生长疾病由PIK3CA基因的体细胞突变引起。
J Pediatr. 2015 Apr;166(4):1048-54.e1-5. doi: 10.1016/j.jpeds.2014.12.069. Epub 2015 Feb 11.
8
New Insights into Wnt-Lrp5/6-β-Catenin Signaling in Mechanotransduction.机械转导中 Wnt-Lrp5/6-β-连环蛋白信号的新见解。
Front Endocrinol (Lausanne). 2015 Jan 20;5:246. doi: 10.3389/fendo.2014.00246. eCollection 2014.
9
Perspectives on osteoporosis therapies.骨质疏松症治疗的观点。
J Endocrinol Invest. 2015 Mar;38(3):303-11. doi: 10.1007/s40618-014-0236-9. Epub 2015 Jan 11.
10
Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches.Wnt 信号通路在骨质疏松症中的作用机制及新型治疗策略
Nat Rev Endocrinol. 2013 Oct;9(10):575-83. doi: 10.1038/nrendo.2013.154. Epub 2013 Aug 13.